Saudi Pharmaceutical Industries & Medical Appliances Corporation’s (SPIMACO) board of directors on May 4 approved forming a risk management committee, the company said in a statement to Tadawul on Thursday.
Members of the committee will serve until the end of the board’s tenth term on April 2, 2019.
SPIMACO’s board also approved forming an investment committee and has appointed its members, in addition to re-forming the nomination and bonuses’ committee for the same period.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}